Moderna, Pfizer a step closer as India exempts foreign Covid vaccines from bridging trials

In a move to pave the way for the availability of vaccines like Pfizer and Moderna in India, the Drugs Controller General of India (DCGI) has exempted foreign Covid-19 vaccines approved by specific nations or health bodies from post-approval bridging trials in the country. DCGI chief VG Somani said the decision to waive trials will only apply to the vaccines that have been approved for restricted use by the US FDA and other countries or which are listed on the WHO Emergency Use Listing (EUL).